Detalles de la búsqueda
1.
ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy.
Cancer Sci
; 115(5): 1680-1687, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38475661
2.
Role of Maximal Transurethral Resection Preceding Partial Cystectomy for Muscle-Invasive Bladder Cancer.
Ann Surg Oncol
; 31(2): 1384-1392, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37884699
3.
PD-1 inhibitor plus oncolytic vaccinia virus is a safe and effective treatment option for metastatic renal cell carcinoma.
Cancer Cell Int
; 24(1): 50, 2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291394
4.
External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study.
Int J Urol
; 30(3): 308-317, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36478459
5.
Predicting factor analysis of postoperative complications after robot-assisted radical cystectomy: Multicenter KORARC database study.
Int J Urol
; 29(9): 939-946, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35137466
6.
Characteristics of BRCA2 Mutated Prostate Cancer at Presentation.
Int J Mol Sci
; 23(21)2022 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36362213
7.
Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases.
Ann Surg Oncol
; 28(4): 2367-2373, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33389298
8.
Oncological outcome according to attainment of pentafecta after robot-assisted radical cystectomy in patients with bladder cancer included in the multicentre KORARC database.
BJU Int
; 127(2): 182-189, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32682331
9.
Lessons learned from clinical outcome and tumor features of patients underwent selective artery embolization due to postoperative bleeding following 2076 partial nephrectomies: propensity scoring matched study.
World J Urol
; 38(5): 1235-1242, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31346763
10.
The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer.
Prostate
; 79(16): 1805-1810, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31483062
11.
Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer.
BMC Cancer
; 18(1): 545, 2018 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29743042
12.
Does robot-assisted radical prostatectomy benefit patients with prostate cancer and bone oligometastases?
BJU Int
; 121(2): 225-231, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28834084
13.
Functional and oncological outcomes of open, laparoscopic and robot-assisted partial nephrectomy: a multicentre comparative matched-pair analyses with a median of 5 years' follow-up.
BJU Int
; 122(4): 618-626, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29645344
14.
The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer.
J Korean Med Sci
; 33(5): e36, 2018 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29349945
15.
Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
Int J Urol
; 25(12): 1006-1014, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30276864
16.
Yonsei nomogram: A predictive model of new-onset chronic kidney disease after on-clamp partial nephrectomy in patients with T1 renal tumors.
Int J Urol
; 25(7): 690-697, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29923226
17.
The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality.
J Urol
; 197(4): 1060-1067, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27847296
18.
Prognostic Significance of Vas Deferens Invasion After Radical Prostatectomy in Patients with Pathological Stage T3b Prostate Cancer.
Ann Surg Oncol
; 24(4): 1143-1149, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27796593
19.
Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy.
BMC Cancer
; 17(1): 789, 2017 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29169347
20.
Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin.
BMC Cancer
; 17(1): 321, 2017 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28482884